
Koninklijke Philips N.V. PHG
€ 22.41
-2.32%
Quartalsbericht 2025-Q4
hinzugefügt 06.05.2026
Koninklijke Philips N.V. Anteile 2011-2026 | PHG
Anteile Jährlich Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 948 M | 933 M | 948 M | 952 M | 904 M | 923 M | 923 M | 927 M | 928 M | 1.33 B | 1.5 B | 1.64 B | 916 M | 825 M | 1.57 B |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.64 B | 825 M | 1.08 B |
Anteile Vierteljährlich Koninklijke Philips N.V.
| 2025-Q4 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 948 M | 933 M | 948 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 948 M | 933 M | 943 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 205.06 | 0.27 % | $ 22.8 B | ||
|
Celcuity
CELC
|
46.8 M | $ 89.08 | -3.79 % | $ 4.17 B | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 4.22 | -6.22 % | $ 5.61 M | ||
|
Castle Biosciences
CSTL
|
29 M | $ 21.08 | - | $ 611 M | ||
|
Fulgent Genetics
FLGT
|
30.8 M | $ 19.02 | 2.78 % | $ 585 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
78.4 M | $ 149.4 | -1.59 % | $ 11.7 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Guardant Health
GH
|
125 M | $ 130.85 | 0.56 % | $ 16.4 B | ||
|
Illumina
ILMN
|
155 M | $ 164.29 | 2.66 % | $ 25.5 B | ||
|
CareDx, Inc
CDNA
|
53.3 M | $ 23.06 | 1.36 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 1.79 | 2.87 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
464 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 101.94 | 1.96 % | $ 6.88 B | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 189.61 | -0.2 % | $ 9.4 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
300 M | $ 1.38 | 0.36 % | $ 414 M | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 473.04 | 1.34 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
20.6 M | $ 1 135.13 | -2.39 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
128 M | $ 11.71 | 2.32 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 4.63 | 1.98 % | $ 429 M | ||
|
National Research Corporation
NRC
|
22.4 M | $ 19.93 | 0.91 % | $ 446 M | ||
|
Natera
NTRA
|
137 M | $ 216.72 | -2.74 % | $ 29.6 B | ||
|
Personalis
PSNL
|
89.2 M | $ 9.69 | -0.62 % | $ 865 M | ||
|
Senseonics Holdings
SENS
|
41.7 M | $ 7.23 | -2.69 % | $ 302 M | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.04 | -0.54 % | $ 4.69 M | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 272.38 | 0.44 % | $ 22.7 B | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 68.29 | -2.53 % | $ 4.08 B | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 486.89 | -1.51 % | $ 184 B | ||
|
Trinity Biotech plc
TRIB
|
359 M | $ 0.67 | 1.61 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
217 M | $ 9.23 | -0.65 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M |